DFS
67
-6
AIZ
54
-3
FIS
51
-4
IFF
53
-3
FSLR
49
-3
SNA
69
-4
KIM
64
-2
HD
44
-5
HUM
52
16
ED
40
-6
HPE
53
2
MCHP
49
4
CRM
62
3
PCG
80
-5
ABT
54
-2
SWKS
46
6
MNST
61
-4
EL
45
2
WMB
66
-2
PYPL
45
-7
DFS
67
-6
AIZ
54
-3
FIS
51
-4
IFF
53
-3
FSLR
49
-3
SNA
69
-4
KIM
64
-2
HD
44
-5
HUM
52
16
ED
40
-6
HPE
53
2
MCHP
49
4
CRM
62
3
PCG
80
-5
ABT
54
-2
SWKS
46
6
MNST
61
-4
EL
45
2
WMB
66
-2
PYPL
45
-7
Financhill
Back

Catalyst Pharmaceuticals 10K Form

Buy
52

CPRX
Catalyst Pharmaceuticals

Last Price:
21.85
Seasonality Move:
-2.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $398.2M
Cash Flow: $64.13M
Price / Cash Flow: 22.18
Annual Sales: $5.14
Price / Book: 4.25

Profitability

EPS (TTM): 0.54000
Net Income (TTM): $68.15M
Gross Margin: $346.24M
Return on Equity: 14.93%
Return on Assets: 12.71%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
  • The Research & Development expenses have been 23.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.14
Quick Ratio: 4.69

Price-to-Earnings

Trailing P/E Ratio: 34.56
Forward P/E Ratio: 10.14

CPRX Technical Analysis vs Fundamental Analysis

Buy
52
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy or a Sell?